Jefferies Financial Group Inc. Axsome Therapeutics, Inc. Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$65.72 - $80.5 $20.8 Million - $25.5 Million	-316,907 Reduced 95.23%	15,859 $1.28 Million
Q1 2024 May 13, 2024	SELL	$69.39 - $97.64 $16 Million - $22.5 Million	-230,569 Reduced 40.93%	332,766 $26.6 Million
Q4 2023 Feb 13, 2024	BUY	$57.42 - $83.61 $582,238 - $847,805	10,140 Added 1.83%	563,335 $44.8 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $38.3 Million - $45.5 Million	553,195 New	553,195 $38.7 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.